Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Ekso Bionics Holdings, Inc.

Ekso Bionics develops and manufactures exoskeleton technology to augment human capabilities. The company focuses on creating wearable robots that enhance mobility and strength for medical and industrial applications.

Ekso Bionics

EksoWorks

Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company’s first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable.

Ekso Bionics is headquartered in San Rafael, California

International Offices:
Ekso Bionics Europe GmbH
Friesenweg 20 
Hamburg, 22763
Germany
Tel: +49 40 800 4049 20

Watch Will and Stephen in their Ekso Indego Personal exoskeletons as they effortlessly incorporate them into their daily routines. From walking in the park to doing household chores, Ekso Indego Personal brings newfound independence and ease to their lives.

Imagine the possibilities: standing tall, walking with confidence, and enjoying everyday activities with your loved ones. With Medicare coverage now available for those who qualify, accessing this revolutionary exoskeleton has never been more achievable.

Speak to your doctor to see if Ekso Indego Personal is right for you, and visit https://hubs.ly/Q02JgZ880 for more information and see if you qualify! 

#EksoIndegoPersonal #Mobility #Exoskeleton #Rehabilitation #DailyLife #Independence #MedicareCoverage #EksoBionics

We love seeing how different centers incorporate Ekso Indego into their therapy sessions! Check out NextStep Orlando Inc working hard with Casey who went to visit them all way from Next Step New Zealand. At Next Step Orlando, they use Ekso Indego to its full potential and really take advantage of its versatility, including its ability to enhance mobility, improve gait training, and support rehabilitation. It's inspiring to see how these advanced features make a real difference in their patients' lives! 

Learn more about Ekso Indego Therapy here: https://bit.ly/46xoTtG

#EksoNR #Rehabilitation #Mobility #NeurologicalRecovery #SpinalCordInjury

EksoEVO is perfect for anyone in a physically demanding job. It’s like having a supportive friend who’s got your back—literally. With EksoEVO, you’ll feel stronger and less fatigued, ready to take on your workday.

💪 Why You'll Love EksoEVO:

Feel Stronger: Handle repetitive tasks with ease.
Stay Safe: Protect yourself from workplace injuries.
Boost Productivity: Get more done without feeling exhausted.
Discover how EksoEVO can change the way you work. Your body will thank you!
https://hubs.la/Q02Jq56l0

#EksoEVO #WorkSmart #StayStrong #SafetyFirst #BoostYourDay #EksoBionics #WorkLife

Today, Ekso Bionics reported second quarter 2024 results, highlighted by record sales of $5.0 million, a total of 37 EksoHealth devices sold, gross margin of 53%, and initial Medicare claims for Ekso Indego Personal currently pending lump-sum reimbursement.

“We are pleased with our significant progress in the second quarter of 2024, highlighted by record sales and the announcement of CMS' national Medicare pricing determination for our Ekso Indego Personal device,” said Scott Davis, Chief Executive Officer of Ekso Bionics.

Read more about our second quarter results in our press release here: https://hubs.ly/Q02JhZ6N0

Imagine washing your face in the sink standing up again. Ekso Indego Personal integrates seamlessly into your daily life, offering those with spinal cord injuries the chance to experience everyday moments with newfound freedom and independence.

Medicare coverage may now be available for those who qualify. Speak to your doctor to see if Ekso Indego Personal is right for you, and visit our website to learn more: https://bit.ly/3AkS0nY

#EksoIndegoPersonal #DailyLiving #Independence #Exoskeleton #MedicareCoverage

We’re excited to announce that we will be at the National Veterans Wheelchair Games in New Orleans from July 25-30, 2024! 🎉
 
Come visit us at booth 312 and see Ekso Indego, our exoskeleton designed to enhance mobility and independence for individuals with spinal cord injuries. Whether you're a veteran or a supporter, we can't wait to show you how Ekso Indego is changing lives.
 
See you there!
 
#EksoBionics #EksoIndego #NationalVeteransWheelchairGames #Mobility #Independence #Veterans #Exoskeleton #NewOrleans2024 Paralyzed Veterans of America (PVA)

msh id	COM:EKSOBIONICS
symbol	EKSO
name	Ekso Bionics Holdings, Inc.
homepage url	https://www.eksobionics.com
country	US
sector	Healthcare
industry	Medical - Instruments & Supplies
market	STOCKS
employee count	70
crunchbase url	-
linkedin url	-
founders	-

market cap	19.73M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.17
growth cost of revenue	0.28
growth depreciation and amortization	57.6
growth ebitda	0.14
growth ebitda ratio	0.39
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-0.03
growth gross profit	0.56
growth gross profit ratio	0.1

COM:EKSOBIONICS

Ekso Bionics

Last Close

0.72

21/11 19:15

Market Cap

19.73M

Beta: -

Volume Today

59.15K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	33.39M
cost of revenue	33.39M
depreciation and amortization	1.7M
ebitda	-13.41M
ebitda ratio	-0.73
eps	-1.1
eps diluted	-1.1
operating expenses	24.81M
operating income	-15.11M
operating income ratio	-0.83

accounts receivables	-1.21M
capital expenditure	-157K
cash at beginning of period	20.53M
cash at end of period	8.64M
inventory	5.05M
working capital ttm	14.53M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-